Get started
SAREPTA THERDRNSAREPTA THERDRNSAREPTA THERDRN

SAREPTA THERDRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

S1RP34 trade ideas

SRPT Sarepta Therapeutics Potential Buyout SoonIf you haven`t bought SRPT here: Then you need to know that there is a Massive catalyst coming! Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November. This week institutions bought calls worth more than $10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17. Some even bought the $210 strike price! They also have a big partnership with the giant Roche Holding AG (RHHBY). I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon! Looking forward to read your opinion about it.
NASDAQ:SRPTLong
by TopgOptions
SRPT (Sarepta) is Bull to at least 72.81Prediction: SRPT (Sarepta) is Bull to at least 72.81 Reasons: A good/decent Bull Pattern has emerged (Before closing) that is pointing upwards, and the Trends momentum is strong enough to push through the current resistance and reach the next resistance point of 72.81. And also, the main index for small biotech XBI is also showing bull signs. As you can see on the chart, the Alligator Mouth has a decent strength, and so does the MA (53.33%), The Oscillators is Neutral (slightly bearish) but the momentum was good, so it is to be expected. Before post/pre market data it had a Sell signal (-27.27%) but with the post/pre market it improved to Neutral (-9.09%) which is a good sign. Also, Volume Flow is on an increasing trend thus giving SRPT more fuel to pump. And finally, the volatility squeeze is not enough for the stock to collapse/reverse so all in all the signs are pointing to bull.
NASDAQ:SRPTLong
by KevInnerTrading
Bollinger Band SqueezeSRPT looks like she will pop soon. The bollinger bands are contracted and are squeezing the keltner channel for a classic bollinger band squeeze. It is not a given which way this will pop, could go up or down..but a move is coming. There are pocket pivots under price Short is a bit over 9%. Negative volume is high on SRPT. Keltner Channels are volatility-based envelopes set above and below an exponential moving average. This indicator is similar to Bollinger Bands, which use the standard deviation to set the bands. Instead of using the standard deviation, Keltner Channels use the Average True Range (ATR) to set channel distance. No recommendation
NASDAQ:SRPT
by lauralea
3
Bottom FishingSome of the biotech industry seems to be recovering after most suffering a long hard fall. SRPT gapped down, way down, did the dead cat bounce dance and regained a bit only to form a symmetrical triangle that broke to the downside. Then a descending triangle and has fallen down from each triangle the designated amount but could fall further. The low during these scenarios was 68.04 which is less than the 3 year low. Some support noted at 67.04. The dead cat bounce is an event pattern as a rule, be it bad earnings or bad news related. Price makes a dramatic drop in a daily swoop down averaging 15 to 30%. Price bounces up, then resumes the downtrend. Biotech is among the top contenders to have a drop down of this magnitude. The semiconductor industry, internet stocks and alternative energy are all on the list among of those more likely to gap down significantly. Utilities, housegold goods and the defense sectors are among those least likely to gap down to this extent. The bollinger bands are contracting, so a move one way or the other is to be expected. No recommendation. Being a bottom dweller can be time consuming )o: Some stocks gap down and can actually be a good buy, and it will improve the odds if the gap down day candle ends as a doji or a bullish candle. Utilities rarely gap down to this extreme, but not to say they do not ever do it. Homebuilders are among those that can gap down like this, but this sector is more likely to recover without further decline than other sectors according to statistics.
NASDAQ:SRPT
by lauralea
7
SRPT - Long This is a stock ive lost on before - so be warned However, it seems so oversold and if price pushes lower I will likely re-enter, the stock has a strong pipeline of goods and has had some good news recently (Amondys 45 FDA approval) which hasnt really been reflected in the stock price. RSI is touching oversold Average Analyst price target is still $130 Price at multi year lows I think taking multiple small positions is the way to play this, to scale in, and allow for protection from the continuation of the sell off in the short term
NASDAQ:SRPTLong
by jevanss25